Source: Eur Respir J 2004; 24: 78-85
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Di Stefano A., Caramori G., Capelli A., Gnemmi I., Ricciardolo F.L., Oates T., Donner C.F., Chung K.F., Barnes P.J., Adcock I.M.. STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. Eur Respir J 2004; 24: 78-85

Member's Comments

No comment yet.

Related content which might interest you: Decreased FOXP3 expression in small airways of smokers with COPD Source: Eur Respir J 2009; 33: 61-67 Year: 2009 Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema Source: Eur Respir J 2001; 17: 946-953 Year: 2001 Expression profile of Th1/Th2 transcription factors T-bet and GATA-3 in sarcoidosis, idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: 3-5 Year: 2004 A high probability of short-range interactions between fibrocytes and CD8+ T cells potentiates the inflammatory response in chronic obstructive pulmonary disease (COPD) lungs Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020 Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 325-331 Year: 2002 STAT4 activation in smokers and patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 359s Year: 2003 Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006 Expression profiling of Th17 associated molecules in bronchoalveolar cells from patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011 Decreased TCR γδ T lymphocytes in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003 The role of regulator and effector T lymphocytes in chronic obstructive pulmonary disease and lung cancer Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 Pulmonary dendritic cells from chronic obstructive pulmonary disease patients suppress lung immune responses through induction of regulatory T cells Source: Annual Congress 2011 - T-cell subsets Year: 2011 The relationship of the transcription factors AP-1 and NF-KB with lung function in the lungs of patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 501s Year: 2001 Decreased pulmonary immunoregulatory/suppressor (CD4+CD25+) T-lymphocytes in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003 A high probability of short-range interactions between fibrocytes and CD8 T cells in chronic obstructive pulmonary disease (COPD) lungs Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019 High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological function Source: Eur Respir J 2006; 28: 113-122 Year: 2006 Lung dendritic cells from chronic obstructive pulmonary disease patients induce type 1 T regulatory cells Source: Annual Congress 2012 - Immunologic mechanisms in COPD and asthma Year: 2012 COPD is associated with reduced pulmonary interstitial expression of pentraxin-3 Source: Eur Respir J 2012; 39: 830-838 Year: 2012 Micro-RNA-125a/b target A20 and MAVS to promote inflammatory and impair antiviral responses in chronic obstructive pulmonary disease Source: International Congress 2016 – Mechanisms of disease Year: 2016 Airway epithelium, lymphocyte, neutrophil and macrophage apoptosis in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008